Copyright Reports & Markets. All rights reserved.

Global Parry-Romberg Syndrome Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Parry-Romberg Syndrome Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Medical Examination
      • 1.4.3 MRI Scan
      • 1.4.4 Serum Test
    • 1.5 Market by Application
      • 1.5.1 Global Parry-Romberg Syndrome Market Share by Application (2014-2025)
      • 1.5.2 Hospital & Clinics
      • 1.5.3 Physical Therapists
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Parry-Romberg Syndrome Market Size
    • 2.2 Parry-Romberg Syndrome Growth Trends by Regions
      • 2.2.1 Parry-Romberg Syndrome Market Size by Regions (2014-2025)
      • 2.2.2 Parry-Romberg Syndrome Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Parry-Romberg Syndrome Market Size by Manufacturers
      • 3.1.1 Global Parry-Romberg Syndrome Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Parry-Romberg Syndrome Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Parry-Romberg Syndrome Market Concentration Ratio (CR5 and HHI)
    • 3.2 Parry-Romberg Syndrome Key Players Head office and Area Served
    • 3.3 Key Players Parry-Romberg Syndrome Product/Solution/Service
    • 3.4 Date of Enter into Parry-Romberg Syndrome Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Parry-Romberg Syndrome Market Size by Type (2014-2019)
    • 4.2 Global Parry-Romberg Syndrome Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Parry-Romberg Syndrome Market Size (2014-2019)
    • 5.2 Parry-Romberg Syndrome Key Players in United States
    • 5.3 United States Parry-Romberg Syndrome Market Size by Type
    • 5.4 United States Parry-Romberg Syndrome Market Size by Application

    6 Europe

    • 6.1 Europe Parry-Romberg Syndrome Market Size (2014-2019)
    • 6.2 Parry-Romberg Syndrome Key Players in Europe
    • 6.3 Europe Parry-Romberg Syndrome Market Size by Type
    • 6.4 Europe Parry-Romberg Syndrome Market Size by Application

    7 China

    • 7.1 China Parry-Romberg Syndrome Market Size (2014-2019)
    • 7.2 Parry-Romberg Syndrome Key Players in China
    • 7.3 China Parry-Romberg Syndrome Market Size by Type
    • 7.4 China Parry-Romberg Syndrome Market Size by Application

    8 Japan

    • 8.1 Japan Parry-Romberg Syndrome Market Size (2014-2019)
    • 8.2 Parry-Romberg Syndrome Key Players in Japan
    • 8.3 Japan Parry-Romberg Syndrome Market Size by Type
    • 8.4 Japan Parry-Romberg Syndrome Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Parry-Romberg Syndrome Market Size (2014-2019)
    • 9.2 Parry-Romberg Syndrome Key Players in Southeast Asia
    • 9.3 Southeast Asia Parry-Romberg Syndrome Market Size by Type
    • 9.4 Southeast Asia Parry-Romberg Syndrome Market Size by Application

    10 India

    • 10.1 India Parry-Romberg Syndrome Market Size (2014-2019)
    • 10.2 Parry-Romberg Syndrome Key Players in India
    • 10.3 India Parry-Romberg Syndrome Market Size by Type
    • 10.4 India Parry-Romberg Syndrome Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Parry-Romberg Syndrome Market Size (2014-2019)
    • 11.2 Parry-Romberg Syndrome Key Players in Central & South America
    • 11.3 Central & South America Parry-Romberg Syndrome Market Size by Type
    • 11.4 Central & South America Parry-Romberg Syndrome Market Size by Application

    12 International Players Profiles

    • 12.1 DePuy Synthes
      • 12.1.1 DePuy Synthes Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Parry-Romberg Syndrome Introduction
      • 12.1.4 DePuy Synthes Revenue in Parry-Romberg Syndrome Business (2014-2019)
      • 12.1.5 DePuy Synthes Recent Development
    • 12.2 Johnson & Johnson Services
      • 12.2.1 Johnson & Johnson Services Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Parry-Romberg Syndrome Introduction
      • 12.2.4 Johnson & Johnson Services Revenue in Parry-Romberg Syndrome Business (2014-2019)
      • 12.2.5 Johnson & Johnson Services Recent Development
    • 12.3 Medtronic
      • 12.3.1 Medtronic Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Parry-Romberg Syndrome Introduction
      • 12.3.4 Medtronic Revenue in Parry-Romberg Syndrome Business (2014-2019)
      • 12.3.5 Medtronic Recent Development
    • 12.4 Abbott
      • 12.4.1 Abbott Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Parry-Romberg Syndrome Introduction
      • 12.4.4 Abbott Revenue in Parry-Romberg Syndrome Business (2014-2019)
      • 12.4.5 Abbott Recent Development
    • 12.5 Immediate Media Company
      • 12.5.1 Immediate Media Company Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Parry-Romberg Syndrome Introduction
      • 12.5.4 Immediate Media Company Revenue in Parry-Romberg Syndrome Business (2014-2019)
      • 12.5.5 Immediate Media Company Recent Development
    • 12.6 Taj Pharmaceuticals
      • 12.6.1 Taj Pharmaceuticals Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Parry-Romberg Syndrome Introduction
      • 12.6.4 Taj Pharmaceuticals Revenue in Parry-Romberg Syndrome Business (2014-2019)
      • 12.6.5 Taj Pharmaceuticals Recent Development
    • 12.7 Pfizer
      • 12.7.1 Pfizer Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Parry-Romberg Syndrome Introduction
      • 12.7.4 Pfizer Revenue in Parry-Romberg Syndrome Business (2014-2019)
      • 12.7.5 Pfizer Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Parry–Romberg syndrome, also known as progressive hemifacial atrophy, is a rare disease characterized by progressive shrinkage and degeneration of the tissues beneath the skin, usually on only one side of the face (hemifacial atrophy) but occasionally extending to other parts of the body. An autoimmune mechanism is suspected, and the syndrome may be a variant of localized scleroderma, but the precise cause and pathogenesis of this acquired disorder remains unknown.
      Medical management may involve immunosuppressive drugs such as methotrexate, corticosteroids, cyclophosphamide, and azathioprine. No randomized controlled trials have yet been conducted to evaluate such treatments, so the benefits have not been clearly established. Affected individuals may benefit from autologous fat transfer or fat grafts to restore a more normal contour to the face. However, greater volume defects may require microsurgical reconstructive surgerywhich may involve the transfer of an island parascapular fasciocutaneous flap or a free flap from the groin, rectus abdominis muscle (Transverse Rectus Abdominis Myocutaneous or "TRAM" flap) or latissimus dorsi muscle to the face.
      In 2018, the global Parry-Romberg Syndrome market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Parry-Romberg Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parry-Romberg Syndrome development in United States, Europe and China.

      The key players covered in this study
      DePuy Synthes
      Johnson & Johnson Services
      Medtronic
      Abbott
      Immediate Media Company
      Taj Pharmaceuticals
      Pfizer
      ...

      Market segment by Type, the product can be split into
      Medical Examination
      MRI Scan
      Serum Test

      Market segment by Application, split into
      Hospital & Clinics
      Physical Therapists

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Parry-Romberg Syndrome status, future forecast, growth opportunity, key market and key players.
      To present the Parry-Romberg Syndrome development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Parry-Romberg Syndrome are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now